Advertisement

Pharmacy World and Science

, Volume 25, Issue 2, pp 65–69 | Cite as

Frequency and trends of interventions of prescriptions in Flemish community pharmacies

  • L. Leemans
  • G. Laekeman
  • L. Veroeveren
  • J. Bulens
  • Ch. Hendrickx
  • W. Keyenberg
  • F. Niesten
  • J. Vandeberg
  • J. Van Hoof
Article

Abstract

Objective: To study the role of the community pharmacist in medication management.Method: Participating Flemish pharmacists quantified their interventions during two weeks by use of validated diagrams. The clinical interventions were recorded in detail, while the technical interventions were only registered. Results: 124 pharmacists participated. Intervention was needed in 4.1% of the total number of prescriptions (n = 87.647). On average, 20.2 technical and 8.4 clinical interventions over a period of 2 weeks per pharmacy were needed. The main problem was missing or incorrect data on administering the drug (23%). Missing or incorrect advice (37.8 %), dose‐related problems (26.1 %) and interactions or contra‐indications (20.2 %) were mentioned as important clinical discrepancies. The pharmacists utilized the patient medication records to solve most of the problems. In one out of five cases, the physician was contacted.Conclusion: Interventions by community pharmacists in medication management have been recorded in this study. The results should be translated into a process of integrated pharmaceutical care.

Belgium Community pharmacy Drug‐related problems Drug‐use evaluation Medication management Pharmacist Prescriptions 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Smith DL. The informational needs of the patient. Pharm Int 1993; July: 168–72.Google Scholar
  2. 2.
    Rupp MT, Schondelmeyer SW, Wilson GT, Krause JE. Documenting prescribing errors and pharmacist interventions in community pharmacy practice. Am Pharm 1988; NS28(9): 574–80.Google Scholar
  3. 3.
    Dobie RL, Rascati KL. Documenting the value of pharmacist interventions. Am Pharm 1994; NS34(5): 50–4.Google Scholar
  4. 4.
    Rupp MT. Evaluation of prescribing errors and pharmacist interventions in community practice: an estimate of 'valueadded'. Am Pharm 1988; NS28(12): 766–70.Google Scholar
  5. 5.
    Cohen I, Rogers P, Burke V, Beilin J. Predictors of medication use, compliance and symptoms of hypotension in a community-based sample of elderly men and women. J Clin Pharmacol Ther 1998; 23: 423–32.Google Scholar
  6. 6.
    Knapp KK, Katzman H, Hambright JS, Albrant DH. Community pharmacist interventions in a capitated pharmacy benefit contract. Am J Health Syst Pharm 1998; 55: 1141–5.Google Scholar
  7. 7.
    Peters-Uddings LM. Dagelijkse interventies door openbare apothekers onderzocht. [Investigation of daily interventions of community pharmacists.] Pharm Wbl 1997; 132 (29): 1010–1.Google Scholar
  8. 8.
    Anonymous. Interventie door apothekers reduceert kosten. [Interventions by pharmacists reduce costs.] Pharm Wbl 2000; 135(24): 855.Google Scholar
  9. 9.
    Hawksworth GM, Chrystyn H. Clinical Pharmacy in primary care. Br J Clin Pharmacol 1998; 45(5): 415–20.Google Scholar
  10. 10.
    Shibley MCh, Pugh CB. Implementation of pharmaceutical care services for patients with hyperlipidemias by independent community pharmacy practitioners. Ann Pharmacother 1997; 31: 713–8.Google Scholar
  11. 11.
    Urquhart J. The odds of the three nons when an aptly prescribed medicine isn't working: non-compliance, non-absorption, non-response. Br J Clin Pharmacol 2002; 54(2): 212–20.Google Scholar
  12. 12.
    Chamba G, Bauguil G, Gallezot J. Evaluation d'actes pharmaceutiques à l'officine. [Evaluation of pharmaceutical acts in community pharmacy.] Faculté de Pharmacie de Lyon, 1999.Google Scholar
  13. 13.
    Van Mil JWF, Dudok Van Heel MC, Boersma M, Tromp ThFJ. Interventions and documentation for drug-related problems in Dutch community pharmacies, Am J Health Syst Pharm 2001; 58: 1428–31.Google Scholar
  14. 14.
    Buurma H, de Smet PAGM, Van den Hoff OP, Egberts ACG. Nature, frequency and determinants of prescription modifications in Dutch community pharmacies. Br J Clin Pharmacol 2001; 52: 85–91.Google Scholar
  15. 15.
    Westein MPD, Herings RMC, Leufkens HGM. Determinants of pharmacists' interventions linked to prescription processing. Pharm World Sci 2001; 23(3): 98–101.Google Scholar
  16. 16.
    Leemans L. Informatiezoekgedrag van de apotheker en zijn rationaliteit bij de aflevering van OTC-producten [Information seeking behaviour of the community pharmacist and his rationality in the delivery of OTC-products], Doctoral dissertation; Faculty of Pharmaceutical Sciences, K.U. Leuven, Belgium, 1996.Google Scholar
  17. 17.
    Watkins RL, Norwood GJ. Impact of Environment and age on quality of consultant behavior among pharmacists. Am J Pharm Educ 1977; 41: 19–22.Google Scholar
  18. 18.
    Cox ER, Fitzpatrick V. Pharmacists' job satisfaction and perceived utilization of skills. Am J Health Syst Pharm 1999; 56: 1733–7.Google Scholar
  19. 19.
    McAuley JW, Mott DA, Schommer JC et al. Assessing the needs of pharmacists and physicians in caring for patients with epilepsy. J Am Pharm Assoc 1999; 39(4): 499–504.Google Scholar
  20. 20.
    Bell HM, McElnay JC, Hughes CM. A self-reported work sampling study in community pharmacy practice. Pharm World Sci 1999; 21(5): 210–6.Google Scholar
  21. 21.
    Hawksworth GH, Corlett AJ, Wright DJ, Chrystyn H. Clinical interventions by community pharmacists during the dispensing process. Br J Clin Pharmacol 1999; 47(6): 695–700.Google Scholar
  22. 22.
    O'Loughlin J, Masson P, Déry V, Fagnan D. The role of community pharmacists in health education and disease prevention: a survey of their interests and needs in relation to cardiovascular disease. Prev Med 1999; 28(3): 324–31.Google Scholar
  23. 23.
    Cohen JJ. Collaborative care: a new model for a new century. Acad Med 2000; 75: 107–12.Google Scholar
  24. 24.
    Perrin AC. Presidential address: the promise of collaborative care. J Dev Behav Pediatr 1999; 20(1): 57–62.Google Scholar
  25. 25.
    Tanskanen P, Airaksinen M, Tanskanen A, Henlund H. Counselling patients on psychotropic medication: physicians opinions on the role of community pharmacists. Pharm World Sci 2000; 22(2): 59–61.Google Scholar
  26. 26.
    Leemans L, Willems L, Kinget R et al. Doctor and pharmacist, hand in glove? Report after a year of clinical internship in Belgium. EHP 2001; 7(1): 34–8.Google Scholar
  27. 27.
    Whaley DL, Tomich DJ, Kelly PC et al. Impact of clinical pharmacist-led guideline enforcement on drug costs, patient satisfaction. Formulary 1999; 34: 257–68.Google Scholar

Copyright information

© Kluwer Academic Publishers 2003

Authors and Affiliations

  • L. Leemans
    • 1
  • G. Laekeman
    • 1
  • L. Veroeveren
    • 2
  • J. Bulens
    • 2
  • Ch. Hendrickx
    • 2
  • W. Keyenberg
    • 2
  • F. Niesten
    • 2
  • J. Vandeberg
    • 2
  • J. Van Hoof
    • 2
  1. 1.Division of Drug and Patient InformationFaculty of Pharmaceutical Sciences, K.ULeuvenBelgium E‐mail
  2. 2.Focus Klinische FarmacieMechelenBelgium

Personalised recommendations